Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Presta

Showing results (91-100 of 184) with videos related to

Pageof 19
Sort By:
Frontiers in Immunology|June 4, 2019
Atypical Chemokine Receptor 3 Generates Guidance Cues for CXCL12-Mediated Endothelial Cell MigrationChiara Tobia, Paola Chiodelli, Andrea Barbieri, et al.
International Journal of Molecular Sciences|March 6, 2021
VEGF-Independent Activation of Müller Cells by the Vitreous from Proliferative Diabetic Retinopathy PatientsSara Rezzola, Jessica Guerra, Adwaid Manu Krishna Chandran, et al.
The American Journal of Pathology|May 22, 2003
Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesisRaffaella Giavazzi, Barbara Sennino, Daniela Coltrini, et al.
International Journal of Molecular Sciences|January 8, 2020
β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe DiseaseMirella Belleri, Daniela Coltrini, Marco Righi, et al.
Cancer Letters|March 21, 2021
Expression of activated VEGFR2 by R1051Q mutation alters the energy metabolism of Sk-Mel-31 melanoma cells by increasing glutamine dependenceElisabetta Grillo, Michela Corsini, Cosetta Ravelli, et al.
FEBS Letters|June 16, 2004
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonistsChiara Urbinati, Antonella Bugatti, Pasqua Oreste, et al.
Blood|March 20, 2004
Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesisMarco Rusnati, Maura Camozzi, Emanuela Moroni, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|April 24, 2026
SEL1L exerts a pro-tumorigenic/pro-angiogenic function in human skin melanomaDaniela Coltrini, Mirella Belleri, Luca Mignani, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 16, 2005
Pentraxin 3 inhibits fibroblast growth factor 2-dependent activation of smooth muscle cells in vitro and neointima formation in vivoMaura Camozzi, Serena Zacchigna, Marco Rusnati, et al.
Journal of the American Chemical Society|August 7, 2012
Role of nanomechanics in canonical and noncanonical pro-angiogenic ligand/VEGF receptor-2 activationDaniele Maiolo, Stefania Mitola, Daria Leali, et al.
Pageof 19

Showing results (91-100 of 184) with videos related to

Sort By:
Pageof 19
Frontiers in Immunology|June 4, 2019
Atypical Chemokine Receptor 3 Generates Guidance Cues for CXCL12-Mediated Endothelial Cell MigrationChiara Tobia, Paola Chiodelli, Andrea Barbieri, et al.
International Journal of Molecular Sciences|March 6, 2021
VEGF-Independent Activation of Müller Cells by the Vitreous from Proliferative Diabetic Retinopathy PatientsSara Rezzola, Jessica Guerra, Adwaid Manu Krishna Chandran, et al.
The American Journal of Pathology|May 22, 2003
Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesisRaffaella Giavazzi, Barbara Sennino, Daniela Coltrini, et al.
International Journal of Molecular Sciences|January 8, 2020
β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe DiseaseMirella Belleri, Daniela Coltrini, Marco Righi, et al.
Cancer Letters|March 21, 2021
Expression of activated VEGFR2 by R1051Q mutation alters the energy metabolism of Sk-Mel-31 melanoma cells by increasing glutamine dependenceElisabetta Grillo, Michela Corsini, Cosetta Ravelli, et al.
FEBS Letters|June 16, 2004
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonistsChiara Urbinati, Antonella Bugatti, Pasqua Oreste, et al.
Blood|March 20, 2004
Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesisMarco Rusnati, Maura Camozzi, Emanuela Moroni, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|April 24, 2026
SEL1L exerts a pro-tumorigenic/pro-angiogenic function in human skin melanomaDaniela Coltrini, Mirella Belleri, Luca Mignani, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 16, 2005
Pentraxin 3 inhibits fibroblast growth factor 2-dependent activation of smooth muscle cells in vitro and neointima formation in vivoMaura Camozzi, Serena Zacchigna, Marco Rusnati, et al.
Journal of the American Chemical Society|August 7, 2012
Role of nanomechanics in canonical and noncanonical pro-angiogenic ligand/VEGF receptor-2 activationDaniele Maiolo, Stefania Mitola, Daria Leali, et al.
Pageof 19